In our study, we confirmed that 6 out of 24 fresh AML primary blasts can be eradicated by GRP78-CAR T cells, while they measured the expression of GRP78 in 14 primary AML samples without testing the cytotoxicity of GRP78-CAR T cells. This evidence concerns the gene HSPA5 and acute myeloid leukemia.